Mumbai, India , is rapidly emerging as a vital hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several firms have established strong manufacturing plants focusing on this critical antiviral medicine . Identifying the precise top manufacturers can be complex due to fluctuating m